About Dr. Jeffrey Braverman
Dr. Braverman is the founder and Medical Director at Braverman
Reproductive Immunology with offices in Long Island and Manhattan.
Dr. Braverman was honored as the youngest graduate at New York University
where he was accepted at the age of 14. He went on to attend Medical School
at The Mount Sinai Medical Center in Manhattan and completed his internship
and residency at the Albert Einstein School of Medicine in New York.
After completing his residency Dr. Braverman established a private medical
practice in Long Island New York. For more than 20 years, Dr. Braverman
has been treating patients with all complications related to Recurrent
Pregnancy Loss and has become one of the nation's leading authorities
in the field Reproductive Immunology. He has managed thousands of cycles
of IUI and IVF with a large majority of his patients suffering from Recurrent
Pregnancy Loss and Failure to initiate and Successfully Complete a Pregnancy
(RPL and FISCP). He has consistently maintained one of the highest success
rates in New York despite the complexity of his case load. For the last
three years in a row, his practice was voted the Best Infertility Practice
on Long Island in an independent poll conducted by the Long Island Press.
Dr. Braverman has published articles in the field of high risk obstetrics
related to IUGR, Gestational Diabetes, and Fetal Distress and has gained
unequaled experience managing as well as delivering this High Risk group
of patients. In fact Dr. Braverman has delivered well over 5000 babies
in his career. He has been featured with his RPL autoimmune patients on
Discovery Channels Baby Story, local TV news stations, and has hosted
numerous radio shows on reproductive immunology and fertility.
He assists and consults with patients from around the world with problems
related to RPL and FISCP. He has designed the most complete panel for
the diagnosis and management of immune related pregnancy complications,
as well as one of the most comprehensive thrombophilia (blood clotting)
His current office staff has all been part of this practice for at least
20 years and most, longer than that. This has also been one of the most
important elements in maintaining our consistency. You will always get
someone knowledgeable when you call the office. Dr. Braverman performs
all his own consults and sonograms. You will never get a "fill in
"when you call for a consult or come in for a visit. He manages every
case from start to finish. Most have his cell phone number and email and
feel free to contact him with any questions. Many of Dr. Braverman's
patients from around the country learn about him in numerous
immunology and fertility chat rooms on the internet, where he has developed a loyal
Dr. Braverman is a member in good standing with the American Society of
Reproductive Immunology, the American Society of Reproductive Medicine,
the European Society of Reproductive Immunology, the American College
of Obstetrics and Gynecology, the New York State Medical Society, the
Nassau County Medical Society and is actively Board Certified from the
American Board of Obstetrics and Gynecology.
Dr Braverman is currently serving as
co-chairman for the American Society of Reproductive Immunology (ASRI)
About Dr. Andrea Vidali, MD
Reproductive Surgeon, Reproductive Endocrinologist
Dr. Vidali brings to Braverman Reproductive Immunology unique expertise.
As a fertility specialist with over 20 years of experience, Dr. Vidali
also has extensive experience in minimally invasive and robotic surgery.
Dr. Vidali specializes in the surgical treatment of endometriosis as it
relates to infertility, implantation failure and pregnancy loss. He has
specific interest in understanding and treating silent endometriosis in
patients with repetitive IVF failure or implantation failure.
He also specializes in non-invasive treatment of uterine fibroids with
laparoscopic myomectomy. In fact, Dr. Vidali pioneered the introduction
of laparoscopic myomectomy for infertility patients, helping to set a
new standard of treatment for women with fibroids who desire fertility1.
Throughout the course of his career Dr. Vidali has held leadership positions
within academics. He was the Director of the Reproductive Endocrinology
and Infertility Division of Hackensack University Medical Center in Hackensack,
NJ, and held two Directorships at Saint Vincent's Catholic Medical
Center in New York City where he was the Director of the Reproductive
Endocrinology and Infertility and the Director of Advanced Laparoscopic Surgery.
After completing his fellowship in Reproductive Endocrinology at Columbia
University, Dr. Vidali embarked on a successful collaboration and partnership
with one of his mentors and laparoscopic surgery and Endometriosis treatment
pioneer Dr. Harry Reich. With Dr. Reich and colleagues, Dr. C.Y. Liu and
Dr. Tamer Seckin, Dr. Vidali partnered to create an advanced gynecologic
surgical practice at St. Vincent's Hospital in New York in 2001.
Dr. Vidali's fellowships include Obstetrics & Gynecology at Georgetown
University and Reproductive Endocrinology and Infertility at Columbia
University College of Physicians & Surgeons.
1: Ribeiro SC, Reich H, Rosenberg J, Guglielminetti E, Vidali A. Laparoscopic
myomectomy and pregnancy outcome in infertile patients. Fertil Steril.
1999 Mar;71(3):571-4. PubMed PMID: 10065802.
About Dr. Darren Ritsick
Darren Ritsick, Ph.D. joined Braverman Reproductive Immunology as Director
of Research last year. Darren and his wife Maggie personally struggled
with recurrent pregnancy loss for more than two years prior to discovering
Dr. Braverman. Happily, under Dr. Braverman's care they quickly achieved
success and were recently blessed with the birth of their beautiful, healthy
and happy baby boy.
Through our interactions with Dr. Ritsick as a patient, it became clear
that he possesses a vast knowledge of reproductive immunology as well
as a sincere passion to help others experiencing the pain and frustration
associated with recurrent pregnancy loss. As Director of Research he will
be involved in helping to further improve and advance our highly personalized
approach to diagnosis and therapy. This will include performing sophisticated
analyses of diagnostic tests and therapeutic approaches currently in use,
as well as helping us to identify, develop and implement the next generation
of diagnostic and therapeutic approaches in reproductive immunology.
Dr. Ritsick received a B.S. in Biology from the University of Richmond,
graduating cum laude with Departmental Honors in Biology. While studying
as an undergraduate, he conducted research on the genetic basis of brain
tumor development and completed an internship at the Center for Immunotherapy
of Cancer and Infectious Diseases at the University of Connecticut Health
Sciences Center. Dr. Ritsick then went on to earn a Ph.D. in Biochemistry,
Cell and Developmental Biology from Emory University for his research
on novel biological roles for reactive oxygen species. His research involved
an interdisciplinary approach including genetics, cell and molecular biology,
and biochemistry. His doctoral work was partially supported by a training
grant from the National Institutes of Health and resulted in six publications
in peer-reviewed journals and presentations at several large scientific
After receiving his Ph.D., Dr. Ritsick served as a Scientific Advisor at
a patent law firm where he participated in various aspects of patent prosecution
in the areas of biotechnology and pharmaceuticals. He worked for a diverse
client base including universities, early stage biotechnology companies,
investors in early stage biotechnology companies, and larger pharmaceutical
companies. A major part of his work was focused on a biotechnology company
developing novel immunomodulatory therapeutics designed to treat autoimmune
diseases and cancer.
Most recently Dr. Ritsick served as Senior Research Project Coordinator
in the Department of Neurosurgery at Emory University where he was involved
in grant preparation and administration and served as coordinator for
the Cancer Cell Biology Program of the Winship Cancer Institute.
About Dr. Nadéra Mansouri-Attia
Dr. Nadéra Mansouri-Attia joined Braverman Reproductive Immunology
after coming here from France and being educated in the finest French
Universities. She received her MSc. cum Laude in Reproductive Physiology
from University Pierre et Marie Curie, Paris VI, focusing on female reproduction.
She received her Ph.D. summa cum Laude in reproductive Physiology and
Development from University Paris-Sud School's of Medicine, Paris XI.
During her Ph.D., she worked on the bovine model in the context of early
pregnancy. Her research focused on studying the feto-maternal crosstalk
and the impact of Assisted Reproductive Technologies (ART) such as In
Vitro Fertilization-Embryo Transfer (IVF-ET) on the pregnancy outcome
using state-of-the-art technologies to analyze global transcriptomic data.
Her work brought novel insight in the control of embryo implantation and
was the first in the world to raise a very new and important concept in
reproductive medicine, the active role of the endometrium as a biosensor
when confronted to the embryo. The same concept was demonstrated as relevant
and probably also essential in humans only three years ago.
During her post-doctoral training at the University College of Dublin (Ireland),
she gained extraordinary experience in the field of Immunology of Reproduction.
Her work characterized the maternal immune response to early pregnancy
with a particular interest on the fertility issues of the high yielding
This has practical benefits and applications to improve reproduction management
and the use of ART for sterile couples. By screening the early response
of the mother to the embryo and by determining at an early stage the pregnancy
outcome, this work will ultimately lead to the development of new strategies
to counteract the maternal immune response defects. Her work has been
recognized as outstanding and was awarded by the French National Academy
for Agriculture and was published in several top journals in the field
Most recently, she has worked on deciphering the molecular mechanisms and
dysregulation of the ovarian function that could lead to disease such
as ovarian cancer at Baylor College of Medicine (BCM) in Houston. Her
knowledge and use of animal models to study reproductive pathologies will
contribute to the development of future therapies for women.
Cassidy Bommer joined Braverman Reproductive Immunology as a Clinical Research
Assistant in the fall of 2013. Cassidy graduated cum laude with Honors
from Mount Holyoke College with a B.A. in Biological Sciences and a certificate
in Culture, Health, and Science.
Cassidy's interest in reproductive health and pregnancy was sparked
by a high school internship with Lifebank USA, the only company to offer
both cord and placenta blood banking for newborns. She went on to work
as a research assistant in the Reproductive Immunology lab of Dr. Sarah
J. Bacon at Mount Holyoke College, studying the post-mating inflammatory
response during pregnancy in mammals.
During her time as an undergraduate, Cassidy served as a research intern
at University Hospital in Newark, NJ in the Obstetrics & Gynecology
department, assisting in the development of a series of case reports on
the treatment of uterine fibroids during pregnancy. She was also lucky
enough to travel to El Salvador with Basic Health International where
she participated in cervical cancer screenings for women in various low
resource regions of the country.
While studying at Harvard University during her junior year, Cassidy's
essay, "The value of the Darwin & Gender project, addressed to
the National Science Foundation," was selected for publication on
the Darwin Correspondence Project (University of Cambridge) website. Her
senior honors thesis, advised by Mount Holyoke College President Lynn
Pasquerella, addressed models of perinatal support for women in the Massachusetts
criminal justice system. While this work deviated from Cassidy's background
in basic and clinical research, it provided her with a launching point
for her interest in a woman's "right to pregnancy."
Cassidy is excited to be working with Dr. Braverman, Dr. Ritsick, and the
entire team at BRI.
Katie Carlson joined Braverman Reproductive Immunology as a Clinical Research
Assistant in the summer of 2015. Katie graduated from the University of
Pennsylvania with a B.A. in Biology and a minor in Science, Technology,
During her time as an undergraduate, Katie served as a research assistant
at the University of Tennessee School of Veterinary Medicine, where she
participated in several projects that used animals to learn more about
cancer and cardiovascular disease. Her favorite project was designed to
study the efficacy of Vesicular Stomatitis Virus in treating cancer in dogs.
Katie went on to complete two years of veterinary school at the University
of Pennsylvania, but decided she wanted to get more involved in human
medicine. This experience was valuable as she can apply the knowledge
she gained about medicine and immunology to her position at BRI.
Katie is passionate about science and medicine, and especially educating
people about these subjects. She is excited to be working with the entire
team at BRI, and is thankful for this opportunity to help women make their
dream of becoming mothers a reality.